Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 176 entries
Sorted by: Best Match Show Resources per page
Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model.

Pain and therapy

Brenne AT, Knudsen AK, Raj SX, Skjelvan L, Lund JÅ, Thronæs M, Løhre ET, Hågensen LÅ, Brunelli C, Kaasa S.
PMID: 32274655
Pain Ther. 2020 Jun;9(1):297-318. doi: 10.1007/s40122-020-00163-7. Epub 2020 Apr 09.

INTRODUCTION: Early access to cancer palliative care is recommended. Descriptions of structures and processes of outpatient palliative care clinics operated within smaller hospitals are scarce. This paper presents the development and operation of a fully integrated cancer and palliative...

Cite
Brenne AT, Knudsen AK, Raj SX, et al. Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model. Pain Ther. 2020;9(1):297-318doi: 10.1007/s40122-020-00163-7.
Brenne, A. T., Knudsen, A. K., Raj, S. X., Skjelvan, L., Lund, J. �. �., Thronæs, M., Løhre, E. T., Hågensen, L. �. �., Brunelli, C., & Kaasa, S. (2020). Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model. Pain and therapy, 9(1), 297-318. https://doi.org/10.1007/s40122-020-00163-7
Brenne, Anne-Tove, et al. "Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model." Pain and therapy vol. 9,1 (2020): 297-318. doi: https://doi.org/10.1007/s40122-020-00163-7
Brenne AT, Knudsen AK, Raj SX, Skjelvan L, Lund JÅ, Thronæs M, Løhre ET, Hågensen LÅ, Brunelli C, Kaasa S. Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model. Pain Ther. 2020 Jun;9(1):297-318. doi: 10.1007/s40122-020-00163-7. Epub 2020 Apr 09. PMID: 32274655; PMCID: PMC7203320.
Copy Download .nbib Format: NLM
Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against .

Frontiers in immunology

Knudsen AS, Björnsson KH, Bassi MR, Walker MR, Kok A, Cristinoi B, Jensen AR, Barfod L.
PMID: 34447381
Front Immunol. 2021 Aug 10;12:716305. doi: 10.3389/fimmu.2021.716305. eCollection 2021.

The highly conserved

Cite
Knudsen AS, Björnsson KH, Bassi MR, et al. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against . Front Immunol. 2021;12:716305doi: 10.3389/fimmu.2021.716305.
Knudsen, A. S., Björnsson, K. H., Bassi, M. R., Walker, M. R., Kok, A., Cristinoi, B., Jensen, A. R., & Barfod, L. (2021). Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against . Frontiers in immunology, 12716305. https://doi.org/10.3389/fimmu.2021.716305
Knudsen, Anne S, et al. "Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against ." Frontiers in immunology vol. 12 (2021): 716305. doi: https://doi.org/10.3389/fimmu.2021.716305
Knudsen AS, Björnsson KH, Bassi MR, Walker MR, Kok A, Cristinoi B, Jensen AR, Barfod L. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against . Front Immunol. 2021 Aug 10;12:716305. doi: 10.3389/fimmu.2021.716305. eCollection 2021. PMID: 34447381; PMCID: PMC8383283.
Copy Download .nbib Format: NLM
Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA.

Clinical chemistry and laboratory medicine

Abildgaard A, Knudsen CS, Bjerg LN, Lund S, Støy J.
PMID: 34480844
Clin Chem Lab Med. 2021 Sep 06;60(1):127-134. doi: 10.1515/cclm-2021-0720. Print 2022 Jan 26.

OBJECTIVES: The glycated haemoglobin fraction AMETHODS: We extracted all routine clinical HbARESULTS: The critical difference (CD) between two POCT results varied between 5.14 and 6.61 mmol/mol (0.47-0.55%), and the analytical imprecision of the DCA Vantage™ (CVCONCLUSIONS: The DCA Vantage™...

Cite
Abildgaard A, Knudsen CS, Bjerg LN, et al. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA. Clin Chem Lab Med. 2021;60(1):127-134doi: 10.1515/cclm-2021-0720.
Abildgaard, A., Knudsen, C. S., Bjerg, L. N., Lund, S., & Støy, J. (2022). Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA. Clinical chemistry and laboratory medicine, 60(1), 127-134. https://doi.org/10.1515/cclm-2021-0720
Abildgaard, Anders, et al. "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA." Clinical chemistry and laboratory medicine vol. 60,1 (2022): 127-134. doi: https://doi.org/10.1515/cclm-2021-0720
Abildgaard A, Knudsen CS, Bjerg LN, Lund S, Støy J. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA. Clin Chem Lab Med. 2021 Sep 06;60(1):127-134. doi: 10.1515/cclm-2021-0720. Print 2022 Jan 26. PMID: 34480844.
Copy Download .nbib Format: NLM
Enterococcal Infections the First Year after Liver Transplantation-A Prospective Cohort Study.

Microorganisms

Rasmussen DB, Møller DL, Knudsen AD, Rostved AA, Knudsen JD, Rasmussen A, Nielsen SD.
PMID: 34442818
Microorganisms. 2021 Aug 15;9(8). doi: 10.3390/microorganisms9081740.

This study aimed to investigate the incidence of enterococcal infections and determine risk factors associated with enterococcal bloodstream infection (BSI) within the first year post-liver transplantation (LTx). We included 321 adult liver transplant recipients transplanted from 2011 to 2019...

Cite
Rasmussen DB, Møller DL, Knudsen AD, et al. Enterococcal Infections the First Year after Liver Transplantation-A Prospective Cohort Study. Microorganisms. 2021;9(8)doi: 10.3390/microorganisms9081740.
Rasmussen, D. B., Møller, D. L., Knudsen, A. D., Rostved, A. A., Knudsen, J. D., Rasmussen, A., & Nielsen, S. D. (2021). Enterococcal Infections the First Year after Liver Transplantation-A Prospective Cohort Study. Microorganisms, 9(8), . https://doi.org/10.3390/microorganisms9081740
Rasmussen, Daniel B, et al. "Enterococcal Infections the First Year after Liver Transplantation-A Prospective Cohort Study." Microorganisms vol. 9,8 (2021). doi: https://doi.org/10.3390/microorganisms9081740
Rasmussen DB, Møller DL, Knudsen AD, Rostved AA, Knudsen JD, Rasmussen A, Nielsen SD. Enterococcal Infections the First Year after Liver Transplantation-A Prospective Cohort Study. Microorganisms. 2021 Aug 15;9(8). doi: 10.3390/microorganisms9081740. PMID: 34442818; PMCID: PMC8400967.
Copy Download .nbib Format: NLM
A model-based approach for targeted neurophysiology in the behaving non-human primate.

International IEEE/EMBS Conference on Neural Engineering : [proceedings]. International IEEE EMBS Conference on Neural Engineering

Knudsen EB, Balewski ZZ, Wallis JD.
PMID: 31367267
Int IEEE EMBS Conf Neural Eng. 2019 Mar;2019:195-198. doi: 10.1109/NER.2019.8716968. Epub 2019 May 20.

Acute neurophysiology in the behaving primate typically relies on traditional manufacturing approaches for the instrumentation necessary for recording. For example, our previous approach consisted of distributing single microelectrodes in a fixed plane situated over a circular patch of frontal...

Cite
Knudsen EB, Balewski ZZ, Wallis JD. A model-based approach for targeted neurophysiology in the behaving non-human primate. Int IEEE EMBS Conf Neural Eng. 2019;2019:195-198doi: 10.1109/NER.2019.8716968.
Knudsen, E. B., Balewski, Z. Z., & Wallis, J. D. (2019). A model-based approach for targeted neurophysiology in the behaving non-human primate. International IEEE/EMBS Conference on Neural Engineering : [proceedings]. International IEEE EMBS Conference on Neural Engineering, 2019195-198. https://doi.org/10.1109/NER.2019.8716968
Knudsen, Eric B, et al. "A model-based approach for targeted neurophysiology in the behaving non-human primate." International IEEE/EMBS Conference on Neural Engineering : [proceedings]. International IEEE EMBS Conference on Neural Engineering vol. 2019 (2019): 195-198. doi: https://doi.org/10.1109/NER.2019.8716968
Knudsen EB, Balewski ZZ, Wallis JD. A model-based approach for targeted neurophysiology in the behaving non-human primate. Int IEEE EMBS Conf Neural Eng. 2019 Mar;2019:195-198. doi: 10.1109/NER.2019.8716968. Epub 2019 May 20. PMID: 31367267; PMCID: PMC6668614.
Copy Download .nbib Format: NLM
2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier.

Toxicological sciences : an official journal of the Society of Toxicology

Trexler AW, Knudsen GA, Nicklisch SCT, Birnbaum LS, Cannon RE.
PMID: 31368499
Toxicol Sci. 2019 Jul 31; doi: 10.1093/toxsci/kfz155. Epub 2019 Jul 31.

2,4,6-Tribromophenol (TBP, CAS No. 118-79-6) is a brominated chemical used in the production of flame-retardant epoxy resins and as a wood preservative. In marine environments, TBP is incorporated into shellfish and consumed by predatory fish. Food processing and water...

Cite
Trexler AW, Knudsen GA, Nicklisch SCT, et al. 2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier. Toxicol Sci. 2019;doi: 10.1093/toxsci/kfz155.
Trexler, A. W., Knudsen, G. A., Nicklisch, S. C. T., Birnbaum, L. S., & Cannon, R. E. (2019). 2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier. Toxicological sciences : an official journal of the Society of Toxicology, . https://doi.org/10.1093/toxsci/kfz155
Trexler, Andrew W, et al. "2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier." Toxicological sciences : an official journal of the Society of Toxicology vol. (2019). doi: https://doi.org/10.1093/toxsci/kfz155
Trexler AW, Knudsen GA, Nicklisch SCT, Birnbaum LS, Cannon RE. 2,4,6-Tribromophenol Exposure Decreases P-glycoprotein Transport at the Blood-Brain Barrier. Toxicol Sci. 2019 Jul 31; doi: 10.1093/toxsci/kfz155. Epub 2019 Jul 31. PMID: 31368499; PMCID: PMC6760274.
Copy Download .nbib Format: NLM
Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Juul Jensen CA, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, Møgelvang R, Gybel-Brask M, Dessau RB, Sørensen E, Harritshøj L, Folke F, Sten C, Engel Møller ME, Benfield T, Ullum H, Jørgensen CS, Erikstrup C, Ostrowski SR, Nielsen SD, Bundgaard H.
PMID: 34543759
Clin Microbiol Infect. 2021 Sep 17; doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17.

OBJECTIVES: Antibodies to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are a key factor in protecting against coronavirus disease 2019 (COVID-19). We examined longitudinal changes in seroprevalence in healthcare workers (HCWs) in Copenhagen and the protective effect of antibodies against...

Cite
Iversen K, Kristensen JH, Hasselbalch RB, et al. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2021;doi: 10.1016/j.cmi.2021.09.005.
Iversen, K., Kristensen, J. H., Hasselbalch, R. B., Pries-Heje, M., Nielsen, P. B., Knudsen, A. D., Fogh, K., Norsk, J. B., Andersen, O., Fischer, T. K., Juul Jensen, C. A., Torp-Pedersen, C., Rungby, J., Ditlev, S. B., Hageman, I., Møgelvang, R., Gybel-Brask, M., Dessau, R. B., Sørensen, E., Harritshøj, L., Folke, F., Sten, C., Engel Møller, M. E., Benfield, T., Ullum, H., Jørgensen, C. S., Erikstrup, C., Ostrowski, S. R., Nielsen, S. D., & Bundgaard, H. (2021). Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, . https://doi.org/10.1016/j.cmi.2021.09.005
Iversen, Kasper, et al. "Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. (2021). doi: https://doi.org/10.1016/j.cmi.2021.09.005
Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Juul Jensen CA, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, Møgelvang R, Gybel-Brask M, Dessau RB, Sørensen E, Harritshøj L, Folke F, Sten C, Engel Møller ME, Benfield T, Ullum H, Jørgensen CS, Erikstrup C, Ostrowski SR, Nielsen SD, Bundgaard H. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2021 Sep 17; doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17. PMID: 34543759; PMCID: PMC8447554.
Copy Download .nbib Format: NLM
Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly.

Clinica chimica acta; international journal of clinical chemistry

Abildgaard A, Knudsen CS, Hoejskov CS, Greibe E, Parkner T.
PMID: 34942168
Clin Chim Acta. 2021 Dec 21;525:62-68. doi: 10.1016/j.cca.2021.12.015. Epub 2021 Dec 21.

BACKGROUND: Plasma/serum vitamin B12 (B12) is often used to screen for B12 deficiency complemented with analysis of methylmalonic acid (MMA) in case of low B12. The concentration of both analytes likely depends on age, and we, therefore, aimed at...

Cite
Abildgaard A, Knudsen CS, Hoejskov CS, et al. Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly. Clin Chim Acta. 2021;525:62-68doi: 10.1016/j.cca.2021.12.015.
Abildgaard, A., Knudsen, C. S., Hoejskov, C. S., Greibe, E., & Parkner, T. (2021). Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly. Clinica chimica acta; international journal of clinical chemistry, 52562-68. https://doi.org/10.1016/j.cca.2021.12.015
Abildgaard, Anders, et al. "Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly." Clinica chimica acta; international journal of clinical chemistry vol. 525 (2021): 62-68. doi: https://doi.org/10.1016/j.cca.2021.12.015
Abildgaard A, Knudsen CS, Hoejskov CS, Greibe E, Parkner T. Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly. Clin Chim Acta. 2021 Dec 21;525:62-68. doi: 10.1016/j.cca.2021.12.015. Epub 2021 Dec 21. PMID: 34942168.
Copy Download .nbib Format: NLM
Synthesis of Hybrid Phosphorated Indenoquinolines and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative agents.

Bioorganic & medicinal chemistry letters

Fuertes M, Selas A, Trejo A, Knudsen BR, Palacios F, Alonso C.
PMID: 34952177
Bioorg Med Chem Lett. 2021 Dec 21;128517. doi: 10.1016/j.bmcl.2021.128517. Epub 2021 Dec 21.

This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as...

Cite
Fuertes M, Selas A, Trejo A, et al. Synthesis of Hybrid Phosphorated Indenoquinolines and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative agents. Bioorg Med Chem Lett. 2021;128517doi: 10.1016/j.bmcl.2021.128517.
Fuertes, M., Selas, A., Trejo, A., Knudsen, B. R., Palacios, F., & Alonso, C. (2021). Synthesis of Hybrid Phosphorated Indenoquinolines and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative agents. Bioorganic & medicinal chemistry letters, 128517. https://doi.org/10.1016/j.bmcl.2021.128517
Fuertes, María, et al. "Synthesis of Hybrid Phosphorated Indenoquinolines and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative agents." Bioorganic & medicinal chemistry letters vol. (2021): 128517. doi: https://doi.org/10.1016/j.bmcl.2021.128517
Fuertes M, Selas A, Trejo A, Knudsen BR, Palacios F, Alonso C. Synthesis of Hybrid Phosphorated Indenoquinolines and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative agents. Bioorg Med Chem Lett. 2021 Dec 21;128517. doi: 10.1016/j.bmcl.2021.128517. Epub 2021 Dec 21. PMID: 34952177.
Copy Download .nbib Format: NLM
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway.

Oncology and therapy

Brenne AT, Løhre ET, Knudsen AK, Thronæs M, Lund JÅ, Kongshaug N, Neverdal MN, Rystad K, Johansen MH, Braseth TI, Kaasa S.
PMID: 34731447
Oncol Ther. 2021 Dec;9(2):671-693. doi: 10.1007/s40487-021-00176-y. Epub 2021 Nov 03.

INTRODUCTION: To improve quality across levels of care, we developed a standardized care pathway (SCP) integrating palliative and oncology services for hospitalized and home-dwelling palliative cancer patients in a rural region.METHODS: A multifaceted implementation strategy was directed towards a...

Cite
Brenne AT, Løhre ET, Knudsen AK, et al. Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway. Oncol Ther. 2021;9(2):671-693doi: 10.1007/s40487-021-00176-y.
Brenne, A. T., Løhre, E. T., Knudsen, A. K., Thronæs, M., Lund, J. �. �., Kongshaug, N., Neverdal, M. N., Rystad, K., Johansen, M. H., Braseth, T. I., & Kaasa, S. (2021). Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway. Oncology and therapy, 9(2), 671-693. https://doi.org/10.1007/s40487-021-00176-y
Brenne, Anne-Tove, et al. "Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway." Oncology and therapy vol. 9,2 (2021): 671-693. doi: https://doi.org/10.1007/s40487-021-00176-y
Brenne AT, Løhre ET, Knudsen AK, Thronæs M, Lund JÅ, Kongshaug N, Neverdal MN, Rystad K, Johansen MH, Braseth TI, Kaasa S. Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway. Oncol Ther. 2021 Dec;9(2):671-693. doi: 10.1007/s40487-021-00176-y. Epub 2021 Nov 03. PMID: 34731447; PMCID: PMC8593089.
Copy Download .nbib Format: NLM
Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

The journal of pathology. Clinical research

Huang F, Ma Z, Pollan S, Yuan X, Swartwood S, Gertych A, Rodriguez M, Mallick J, Bhele S, Guindi M, Dhall D, Walts AE, Bose S, de Peralta Venturina M, Marchevsky AM, Luthringer DJ, Feller SM, Berman B, Freeman MR, Alvord WG, Vande Woude G, Amin MB, Knudsen BS.
PMID: 27785366
J Pathol Clin Res. 2016 Jul 01;2(4):210-222. doi: 10.1002/cjp2.49. eCollection 2016 Oct.

The limited clinical success of anti-HGF/MET drugs can be attributed to the lack of predictive biomarkers that adequately select patients for treatment. We demonstrate here that quantitative digital imaging of formalin fixed paraffin embedded tissues stained by immunohistochemistry can...

Cite
Huang F, Ma Z, Pollan S, et al. Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. J Pathol Clin Res. 2016;2(4):210-222doi: 10.1002/cjp2.49.
Huang, F., Ma, Z., Pollan, S., Yuan, X., Swartwood, S., Gertych, A., Rodriguez, M., Mallick, J., Bhele, S., Guindi, M., Dhall, D., Walts, A. E., Bose, S., de Peralta Venturina, M., Marchevsky, A. M., Luthringer, D. J., Feller, S. M., Berman, B., Freeman, M. R., Alvord, W. G., Vande Woude, G., Amin, M. B., & Knudsen, B. S. (2016). Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. The journal of pathology. Clinical research, 2(4), 210-222. https://doi.org/10.1002/cjp2.49
Huang, Fangjin, et al. "Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET." The journal of pathology. Clinical research vol. 2,4 (2016): 210-222. doi: https://doi.org/10.1002/cjp2.49
Huang F, Ma Z, Pollan S, Yuan X, Swartwood S, Gertych A, Rodriguez M, Mallick J, Bhele S, Guindi M, Dhall D, Walts AE, Bose S, de Peralta Venturina M, Marchevsky AM, Luthringer DJ, Feller SM, Berman B, Freeman MR, Alvord WG, Vande Woude G, Amin MB, Knudsen BS. Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. J Pathol Clin Res. 2016 Jul 01;2(4):210-222. doi: 10.1002/cjp2.49. eCollection 2016 Oct. PMID: 27785366; PMCID: PMC5068192.
Copy Download .nbib Format: NLM
Correction to: Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics.

Journal of clinical monitoring and computing

Gibson LE, Knudsen AS, Arney D, Deng H, Sims NM, Peterfreund RA.
PMID: 34989950
J Clin Monit Comput. 2022 Jan 06; doi: 10.1007/s10877-021-00801-1. Epub 2022 Jan 06.

No abstract available.

Cite
Gibson LE, Knudsen AS, Arney D, et al. Correction to: Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics. J Clin Monit Comput. 2022;doi: 10.1007/s10877-021-00801-1.
Gibson, L. E., Knudsen, A. S., Arney, D., Deng, H., Sims, N. M., & Peterfreund, R. A. (2022). Correction to: Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics. Journal of clinical monitoring and computing, . https://doi.org/10.1007/s10877-021-00801-1
Gibson, Lauren E, et al. "Correction to: Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics." Journal of clinical monitoring and computing vol. (2022). doi: https://doi.org/10.1007/s10877-021-00801-1
Gibson LE, Knudsen AS, Arney D, Deng H, Sims NM, Peterfreund RA. Correction to: Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics. J Clin Monit Comput. 2022 Jan 06; doi: 10.1007/s10877-021-00801-1. Epub 2022 Jan 06. PMID: 34989950.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 176 entries